Porphyria cutanea tarda unmasked by supratherapeutic estrogen during gender-affirming hormone therapy

Stephanie R Jackson Cullison; Jaroslaw J Jedrych; Alaina J James

doi:10.1016/j.jdcr.2020.04.036

Porphyria cutanea tarda unmasked by supratherapeutic estrogen during gender-affirming hormone therapy

JAAD Case Rep. 2020 May 11;6(7):675-678. doi: 10.1016/j.jdcr.2020.04.036. eCollection 2020 Jul.

Authors

Stephanie R Jackson Cullison¹, Jaroslaw J Jedrych², Alaina J James¹

Affiliations

¹ Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
² Department of Dermatology, The Johns Hopkins University, Baltimore, Maryland.

No abstract available

Keywords: HT, hormone therapy; PCT, porphyria cutanea tarda; estradiol; gender minority; hormone therapy; porphyria cutanea tarda; progesterone; transgender.

Publication types

Case Reports